Harmony Biosciences Inc.

NASDAQ: HRMY · Real-Time Price · USD
36.81
0.30 (0.82%)
At close: Aug 15, 2025, 12:49 PM

Harmony Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
714.73M 582.02M 437.86M 305.44M
Cost of Revenue
156.81M 121.24M 83.48M 55.52M
Gross Profit
557.92M 460.79M 354.37M 249.92M
Operating Income
190.83M 192.03M 120.19M 68.7M
Interest Income
18.54M 14.73M 3.13M 223K
Pretax Income
191.8M 173.4M 104.69M 37.43M
Net Income
145.49M 128.85M 181.47M 34.6M
Selling & General & Admin
221.27M 192.69M 163.3M 132.03M
Research & Development
145.82M 76.06M 70.89M 30.37M
Other Expenses
n/a n/a 169K 16K
Operating Expenses
367.09M 268.76M 234.19M 162.39M
Interest Expense
17.5M 23.76M 18.8M 23.97M
Selling & Marketing Expenses
110.92M 97.4M 79.28M 68.12M
Cost & Expenses
523.91M 389.99M 317.67M 217.91M
Income Tax Expense
46.31M 44.54M -76.78M 2.83M
Shares Outstanding (Basic)
56.88M 59.47M 59.17M 57.53M
Shares Outstanding (Diluted)
57.87M 60.37M 61.1M 59.21M
EPS (Basic)
2.56 2.17 3.07 0.60
EPS (Diluted)
2.51 2.13 2.97 0.58
EBITDA
233.41M 221.51M 143.57M 106.37M
EBIT
209.3M 197.15M 120.19M 61.62M
Depreciation & Amortization
24.11M 24.36M 23.39M 18.84M